FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model

Abstract

The US Food and Drug Administration (FDA) issued orders in July 2020 authorising Philip Morris Products S.A. to market its heated tobacco product (HTP) IQOS inside the USA with claims...